Table 1 Distribution of carbapenemase genes in CIM-positive P. aeruginosa isolates collected within the Netherlands between 2015 and 2017.

From: National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017

Carbapenemase PCR

Sampling year

Total

Carbapenemase allele

Sampling year

Total

2015

2016

2017

2015

2016

2017

CIM-positive

blaVIM-2

19

16

48

83

blaVIM

31

16

48

95

blaIMP-13

2

1

 

3

blaIMP

3

2

4

9

blaIMP-1

  

2

2

blaNDM

 

1

2

3

blaIMP-7

1

 

1

2

PCR negative

4

8

5

17

blaIMP-8

  

1

1

Total

38

27

59

124

blaIMP-26

 

1

 

1

CIM-negative

blaNDM-1

 

1

2

3

PCR negative

311

372

414

1097

blaGES-5

1

 

2

3

Total

349

399

473

1221

No carba gene found

3

8

3

14

     

Total

26

27

59

112

  1. In the left table, the results from CIM tests and multiplex PCRs for all isolates included in the study are shown. From 1221 P. aeruginosa isolates that were included, 124 (10%) were CIM-positive. In 107 CIM-positive isolates, a carbapenemase gene was also detected. All blaKPC and blaOXA-48 PCRs were negative, and are therefore not shown. In the right table, NGS results are shown. From the 124 CIM-positive isolates, 112 were sequenced, and the blaVIM-2 allele was discovered in 83 (74%) isolates.
  2. VIM Verona Integron-encoded Metallo-beta-lactamase, IMP Imipenem Metallo-beta-lactamase, NDM New Delhi Metallo-beta-lactamase, GES Guiana Extended-Spectrum beta-lactamase, Carba carbapenemase.